Alliancebernstein L.P. Has $232.38 Million Stock Holdings in HCA Healthcare, Inc. $HCA

Alliancebernstein L.P. decreased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 9.2% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 545,241 shares of the company’s stock after selling 55,007 shares during the quarter. Alliancebernstein L.P. owned about 0.24% of HCA Healthcare worth $232,382,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Norges Bank bought a new stake in HCA Healthcare in the 2nd quarter valued at $1,152,408,000. Pacer Advisors Inc. boosted its holdings in shares of HCA Healthcare by 6,115.3% during the 3rd quarter. Pacer Advisors Inc. now owns 911,096 shares of the company’s stock worth $388,309,000 after buying an additional 896,437 shares during the period. Viking Global Investors LP raised its holdings in HCA Healthcare by 58.5% in the 2nd quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock valued at $717,214,000 after acquiring an additional 690,773 shares during the period. Mondrian Investment Partners LTD bought a new position in shares of HCA Healthcare during the third quarter worth approximately $106,605,000. Finally, HRT Financial LP bought a new stake in HCA Healthcare in the 2nd quarter valued at $81,596,000. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Trading Up 0.2%

HCA Healthcare stock opened at $533.39 on Monday. The company has a market capitalization of $119.28 billion, a PE ratio of 18.79, a P/E/G ratio of 1.64 and a beta of 1.34. The stock has a 50-day moving average price of $507.05 and a two-hundred day moving average price of $470.48. HCA Healthcare, Inc. has a 12 month low of $313.21 and a 12 month high of $556.52.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.37 by $0.64. The business had revenue of $19.51 billion during the quarter, compared to analyst estimates of $19.67 billion. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The firm’s quarterly revenue was up 6.7% on a year-over-year basis. During the same quarter last year, the business earned $6.22 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th will be given a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, March 17th. This represents a $3.12 dividend on an annualized basis and a yield of 0.6%. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.72. HCA Healthcare’s payout ratio is currently 10.15%.

Insider Activity

In other HCA Healthcare news, EVP Michael S. Cuffe sold 1,500 shares of the company’s stock in a transaction on Tuesday, February 3rd. The shares were sold at an average price of $498.09, for a total transaction of $747,135.00. Following the sale, the executive vice president owned 30,003 shares of the company’s stock, valued at approximately $14,944,194.27. This represents a 4.76% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, SVP Jennifer Berres sold 8,020 shares of the company’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total value of $4,126,931.60. Following the sale, the senior vice president owned 11,993 shares in the company, valued at approximately $6,171,357.94. The trade was a 40.07% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 15,214 shares of company stock worth $7,797,595 over the last quarter. Company insiders own 1.30% of the company’s stock.

Analyst Ratings Changes

HCA has been the topic of several research reports. Wall Street Zen downgraded shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, February 14th. Oppenheimer upped their target price on HCA Healthcare from $500.00 to $540.00 and gave the company an “outperform” rating in a research report on Wednesday, January 28th. Mizuho boosted their price target on HCA Healthcare from $540.00 to $585.00 and gave the company an “outperform” rating in a research note on Wednesday, February 25th. Truist Financial raised their target price on shares of HCA Healthcare from $520.00 to $546.00 and gave the company a “buy” rating in a report on Wednesday, January 28th. Finally, TD Cowen upped their target price on HCA Healthcare from $529.00 to $561.00 and gave the stock a “buy” rating in a research note on Tuesday, March 10th. Sixteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $537.73.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.